Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Drug Metabolism and Personalized Therapy

Official journal of the European Society of Pharmacogenomics and Personalised Therapy

Editor-in-Chief: Llerena, Adrián

Editorial Board: Benjeddou, Mongi / Chen, Bing / Dahl, Marja-Liisa / Devinsky, Ferdinand / Hirata, Rosario / Hubacek, Jaroslav A. / Ingelman-Sundberg, Magnus / Maitland-van der Zee, Anke-Hilse / Manolopoulos, Vangelis G. / Marc, Janja / Melichar, Bohuslav / Meyer, Urs A. / Nair, Sujit / Nofziger, Charity / Peiro, Ana / Sadee, Wolfgang / Salazar, Luis A. / Simmaco, Maurizio / Turpeinen, Miia / Schaik, Ron / Shin, Jae-Gook / Visvikis-Siest, Sophie / Zanger, Ulrich M.

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.277
Source Normalized Impact per Paper (SNIP) 2018: 0.446

See all formats and pricing
More options …
Volume 26, Issue 2


Clopidogrel pharmacogenetics: metabolism and drug interactions

Sandra L. Close
Published Online: 2011-08-05 | DOI: https://doi.org/10.1515/dmdi.2011.002


The thienopyridine, clopidogrel bisulfate (clopidogrel), is the most widely prescribed antiplatelet therapy in the world. Clopidogrel, alone or in conjunction with aspirin as part of a dual antiplatelet therapy regimen, is the standard of care for reducing ischemic events in patients with acute coronary syndrome, recent myocardial infarction, recent stroke, or established peripheral artery disease. Initially approved for use in 1997, the label was updated by both the USA Food and Drug Administration and the European Medicines Agency in 2009 to include information regarding cytochrome P450 (CYP) genotype status and concomitant proton pump inhibitor use. Labeling warns of reduced effectiveness in those with impaired CYP2C19 function and to avoid concomitant clopidogrel use with drugs that are strong or moderate CYP2C19 inhibitors, such as omeprazole. The interpretation of this warning and the implementation in clinical practice is not without controversy. The following review provides a summary of the published evidence regarding CYP2C19 function, both genotype status and drug inhibition from concomitant proton pump inhibitors use, and response to clopidogrel.

Keywords: antiplatelet therapy; clopidogrel; CYP2C19; cytochrome P450; proton pump inhibitors

About the article

Corresponding author: Sandra L. Close, PhD, Indiana University School of Medicine, Division of Clinical Pharmacology, 11300 Geist Bay Court, Fishers, IN 46040 USA Tel.: +1-317-578-9879, Fax: +1-317-863-5655

Received: 2011-02-07

Accepted: 2011-06-27

Published Online: 2011-08-05

Published in Print: 2011-08-01

Citation Information: Drug Metabolism and Drug Interactions, Volume 26, Issue 2, Pages 45–51, ISSN (Online) 2191-0162, ISSN (Print) 0792-5077, DOI: https://doi.org/10.1515/dmdi.2011.002.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Xavier Boulenc, Nassim Djebli, Juan Shi, Laurent Perrin, William Brian, Robert Van Horn, and Fabrice Hurbin
Drug Metabolism and Disposition, 2012, Volume 40, Number 1, Page 187
Vasiliki Tsigkou, Gerasimos Siasos, Kleanthis Rovos, Niki Tripyla, and Dimitris Tousoulis
Current Opinion in Pharmacology, 2018, Volume 39, Page 43
S Harada, Y Zhou, S Duncan, AR Armstead, GM Coshatt, C Dillon, BC Brott, J Willig, JA Alsip, WB Hillegass, and NA Limdi
Clinical Pharmacology & Therapeutics, 2017, Volume 102, Number 3, Page 493
Wang Zi-Liang, Liang Xiao-Dong, Li Tian-Xiao, Zhu Liang-Fu, Xue Jiang-Yu, Bai Wei-Xing, He Ying-Kun, Xu Gang-Qin, Shao Qiu-Ji, Li Li, Feng Guang, and Li Zhao-Shuo
International Journal of Stroke, 2016, Page 174749301667798
Csilla Sipeky, Agnes Weber, Melinda Szabo, Bela I. Melegh, Ingrid Janicsek, Greta Tarlos, Istvan Szabo, Katalin Sumegi, and Bela Melegh
Molecular Biology Reports, 2013, Volume 40, Number 8, Page 4727
Adriana Dana Oprea and Wanda M. Popescu
Journal of Cardiothoracic and Vascular Anesthesia, 2013, Volume 27, Number 4, Page 779
Klaus Görlinger, Lars Bergmann, and Daniel Dirkmann
Best Practice & Research Clinical Anaesthesiology, 2012, Volume 26, Number 2, Page 179

Comments (0)

Please log in or register to comment.
Log in